Profiel
Tracy Newbold formerly worked at United Therapeutics Corp., as Senior Director-Operations from 2011 to 2017, Atox Bio Ltd., as Senior Director-Clinical Operations from 2017 to 2020, Immunovant, Inc., as Senior Director-Clinical Operations in 2020, and Lexicon Pharmaceuticals, Inc., as Vice President-Clinical Operations.
Ms. Newbold received her undergraduate degree from The University of North Carolina at Chapel Hill.
Eerdere bekende functies van Tracy Newbold
| Bedrijven | Functie | Einde |
|---|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Corporate Officer/Principal | 01-01-2020 |
| UNITED THERAPEUTICS CORPORATION | Operationeel Directeur | 01-01-2017 |
| LEXICON PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
| IMMUNOVANT, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Tracy Newbold
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Immunovant, Inc.
Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
















